This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 IDC, designated SPE2DB, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of Department of Defense (DoD) healthcare facilities worldwide.
Under this IDC, DMS Pharmaceutical Group provides both routine and critical medications, including branded and generic prescription drugs, over-the-counter products, biologics, and medical consumables. Key items delivered through task orders include pharmaceuticals such as flumazenil injections, prednisone tablets, epinephrine auto-injectors, contraceptives like Mirena and Nexplanon, oncology drugs like Keytruda and Kadcyla, and specialty medications including Nucala and Xolair. DMS Pharmaceutical Group's status as a woman-owned small business allows it to secure direct awards for these pharmaceutical Prime Vendor programs supporting military medical facilities globally.
Generated 1/9/25, 9:03 AM